1. Cutaneous lymphocyte antigen (CLA) is a potential therapeutic target in cutaneous T cell lymphoma. (September 2022) Authors: Poglio, S; Péru, S; Prochazkova-Carlotti, M; Cherrier, F; Velazquez, J; Richard, E; Idrissi, Y; Cappellen, D; Azzi-Martin, L; Pham-Ledard, A; Beylot-Barry, M; Merlio, JP Journal: European journal of cancer Issue: Volume 173(2022)Supplement 1 Page Start: S5 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. First xenograft and cell line of primary cutaneous diffuse large B-cell lymphoma, leg type. (September 2022) Authors: Prochazkova-Carlotti, M; Gros, A; Richard, E; Cherrier, F; Laharanne, E; Idrissi, Y; Baron, C; Poglio, S; Ducharme, O; Menguy, S; Pham-Ledard, A; Beylot-Barry, M; Merlio, JP; Bresson-Bepoldin, L Journal: European journal of cancer Issue: Volume 173(2022)Supplement 1 Page Start: S16 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Proliferative tumor infiltrating lymphocytes within microenvironment impact prognosis in cutaneous B-cell lymphomas. (September 2022) Authors: Pham-Ledard, A; Menguy, S; Prochazkova-Carlotti, M; Azzi-Martin, L; Ferte, T; Bresson-Bepoldin, L; Vergier, B; Merlio, JP; Beylot-Barry, M Journal: European journal of cancer Issue: Volume 173(2022)Supplement 1 Page Start: S6 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Transcriptomic landscape of primary cutaneous diffuse large B-cell lymphoma, leg type reveals novel therapeutic clues. (September 2022) Authors: Gros, A; Gerber, Z; Menguy, S; Ducharme, O; Bresson-Bepoldin, L; Vergier, B; Beylot-Barry, M; Pham-Ledard, A; Merlio, JP Journal: European journal of cancer Issue: Volume 173(2022)Supplement 1 Page Start: S9 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗